Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $782.9700 (-0.01%) ($781.3000 - $782.9700) on Fri. Jun. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 78 | Latest Price | $782.9700(-0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.9% a day on average for past five trading days. | Weekly Trend | REGN advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(44%) DIA(31%) VYM(28%) XLF(28%) | Factors Impacting REGN price | REGN will decline at least -0.755% in a week (0% probabilities). VXX(-24%) VIXM(-21%) TBT(-5%) ACES(-5%) UUP(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $766.6(2.14%) | 10 Day Moving Average | $756.9(3.44%) | 20 Day Moving Average | $748.06(4.67%) | To recent high | -5.7% | To recent low | 8% | Market Cap | $83.017b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |